Details
Category: Volume 08 Issue 01 January 2020
Hits: 1092

Title: A Study of Lipid Profile in Smokers and Tobacco Chewers and their Correlation with Coronary Artery Disease (CAD) in Intensive Care Unit

Authors: Dr Nisha, Dr Uday.G, Dr Akhil Koundinya

 DOI: https://dx.doi.org/10.18535/jmscr/v8i1.33

Abstract

Introduction: Smoking and tobacco chewing forms a major killer of this era. It changes lipid profile which increases risk of coronary heart disease. Smoking and tobacco chewing is associated with an increased risk of atherosclerotic vascular disease. ABI is reliable indicator of high coronary risk and is significantly related to disease of coronary artery disease.

Aim: The aim of study is to study lipid profile in smokers and tobacco chewers and the correlation of their habit with coronary artery disease.

Material and Method: Total 125 individuals who admitted in intensive care unit at Mallareddy hospital from 2018-2019 were taken for the study out of which 100 were patients and 25 were control. The study was conducted in 5 groups of both sex from age (20-70 years) with BMI<27.each group contain 25 subjects. The serum lipid profile level were calculated after overnight fasting and ankle brachial index was calculated and correlation of each group with ABI with CAD grading was done.

Result: smokers and tobacco chewers have dyslipidemic changes and increase incidence of CAD than non-smokers. As the no of years of habit increased the clinical and CAD grading of ABI increased.

Conclusion: Both tobacco chewers and smokers (cigarette and bidi smokers) are at increased risk of coronary artery disease as compared to non-tobacco consuming and non-smoking population. Our research indicated that ABI could be a useful method in assessing both the atherosclerotic risk factors and the degree of coronary involvement.

Keywords: lipid profile, CAD, atherosclerosis, ABI, coronary artery disease, smoking.

References

  1. Kumari BR. A study of lipid profile in smokers and non smokers of different age groups. Journal of Evolution of Medical and Dental Sciences 2013;2(40):7591-7.
  2. Dwivedi S, Prabhu KM, Singh G, Kumar N, Lal MK. Coronary risk variables in young asymptomatic smokers. Indian J Med Res. 2005 Sep;122(3):205-10.
  3. Kamble PK, Rode MV, Phatak MS, Tayade P. Is Smokeless Tobacco use a risk factor for Coronary artery disease? A comparative study of smokers and smokeless tobacco users. Indian Journal of Basic & Applied Medical Research. 2011;1(1):22-30.
  4. WHO report on the global tobacco epidemic, 2009: implementing smoke-free environments, WHO (2009), Geneva. Available from: http://www.who.int/tobacco/mpower/2009/en/. Accessed on 10.06.2017.
  5. Simons LA, Simons J, Jones AS. The interaction of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community. Aust NZ J Med.1984;14:215–21.
  6. Kohout M, Kohoutova B, Heimberg M. Theregulation of hepatic triglyceride metabolism by free fatty acids. J Biol Chem. 1971;246 (16):5067-74.
  7. Goh EH, Heimberg M. Stimulation of hepatic cholesterolbiosynthesis by oleic acid. BiochemBiophys Res Commun. 1973; 55 (2):382-8.
  8. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population based study in middle-aged men. J Am Coll Cardiol. 1999; 34(6):1784-90.
  9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(SupplS):S5-67.
  10. Dachun X, Jue L, Liling Z, Yawei X, Dayi H, Pagoto SL, et al. Sensitivity and specificity of the ankle--brachial index to diagnose peripheral artery disease: a structured review. Vasc Med 2010;15(5):361-9.
  11. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use. N Engl J Med.1994;330:907–12.
  12. Behera D, Uppal R, Majumdar S. Urinary levels of nicotine & cotinine in tobacco users. Indian J Med Res.2003;118:129–33.
  13. Simons LA, Simons J, Jones AS. The interaction of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community. Aust NZ J Med.1984;14:215–2.
  14. Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogenperoxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 1993;686:12–28.
  15. Smith CJ, Fischer Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis2001;158:257–67.
  16. Pryor WA, Stone K, Zang LY, Bermudez E. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol1998;11:441–8.
  17. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med1998;3:21–8.
  18. Black HR. Smoking and cardiovascular disease. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis and Management, 2nd New York: Raven Press Ltd.,1995:2621–47.
  19. Park K. Coronary heart disease. In: Park’s Textbook of Preventive and Social Medicine, 19th Jabalpur: Banarsidas Bhanot Publishers, 2007. pp.303–9.

Corresponding Author

Dr Nisha

Dept of Internal Medicine, Mallareddy Medical Collage & Research Center, Hyderabad, Telangana, India